Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …

Cannabis is the most commonly used substance of abuse in the United States after alcohol
and tobacco. With a recent increase in the rates of cannabis use disorder (CUD) and a …

Elite athletes suffer many mental health symptoms and disorders at rates equivalent to or
exceeding those of the general population. COVID-19 has created new strains on elite …

Cannabis use disorder (CUD) is widespread, and there is no pharmacotherapy to facilitate
its treatment. AEF0117, the first of a new pharmacological class, is a signaling-specific …

Background Observational data and preliminary studies suggest serotonin 2A agonist
psychedelics may hold potential in treating a variety of substance use disorders (SUDs) …

Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients
to provide guidance on its safety and efficacy. Although there has been an increase in …

There have been dramatic changes worldwide in the attitudes toward and consumption of
recreational and medical cannabis. Cannabinoid receptors, which mediate the actions of …

Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …

Cannabis is the most frequently used illicit drug in the United States with more than 45
million users of whom one-third suffer from a cannabis use disorder (CUD). Despite its high …

The prevalence of cannabis abuse and dependence has been increasing among both
adolescents and adults in the United States. This chapter reviews the reviews psychosocial …